Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13951445 | 0.85 | MMP8 (0.33) | MMP8DGAT1 | |
| SCHEMBL12549769 | 0.83 | MMP8 (0.53) | MMP8 | |
| SCHEMBL14548588 | 0.83 | MMP8 (0.38) | MMP8 | |
| SCHEMBL10304753 | 0.83 | MMP8 (0.38) | MMP8DGAT1 | |
| SCHEMBL12135656 | 0.82 | MMP8 (0.42) | MMP8DGAT1 | |
| SCHEMBL25612819 | 0.81 | DGAT1 (0.38) | DGAT1 | |
| SCHEMBL14548589 | 0.80 | MMP8 (0.36) | MMP8 | |
| SCHEMBL12549399 | 0.80 | MMP8 (0.39) | MMP8 | |
| SCHEMBL12549385 | 0.79 | MMP8 (0.41) | MMP8DGAT1 | |
| SCHEMBL12677757 | 0.79 | MMP8 (0.35) | MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120320123-A1 | INK SET AND IMAGE FORMING METHOD | FUJIFILM CORPORATION (JP) | 2012-12-20 | — | — | US | disclosed |
| US-20120146264-A1 | RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND PROCESS FOR MAKING RELIEF PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2012-06-14 | — | — | US | disclosed |
| US-20120056930-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, INKJET RECORDING METHOD, AND INKJET PRINTED ARTICLE | FUJIFILM CORPORATION (JP) | 2012-03-08 | — | — | US | disclosed |
| EP-2371912-A1 | Active radiation curable ink composition, ink composition for inkjet recording, printed matter, and method of producing molded article of printed matter | Fujifilm Corporation (JP) | 2011-10-05 | — | — | EP | disclosed |
| EP-2343195-A1 | LITHOGRAPHIC PRINTING ORIGINAL PLATE, METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE, AND POLYMERIZABLE MONOMER | FUJIFILM Corporation (JP) | 2011-07-13 | — | — | EP | disclosed |
| US-7897711-B2 | Organic-inorganic hybrid composition, method for producing the same, molding and optical component | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-7811742-B2 | Lithographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| EP-2135739-A2 | Relief printing plate precursor for laser engraving, relief printing plate, and process for producing relief printing plate | FUJIFILM Corporation (JP) | 2009-12-23 | — | — | EP | disclosed |
| US-20080268372-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20070224538-A1 | Positive Resist Compositions and Process for the Formation of Resist Patterns With the Same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-7192683-B2 | Planographic printing plate precursor | FUJI PHOTO FILM CO., LTD (JP) | 2007-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120146264-A1 | RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND PROCESS FOR MAKING RELIEF PRINTING PLATE | EIF3L, EIF2B1, EIF2B5 | MMP8 3064/4885DGAT1 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.